Primary Cutaneous CD8-Positive Aggressive Epidermotropic T-Cell Lymphoma

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB18258DR-011 / 2Recruiting1